Maharjan, S.; Lee, M.-G.; Kim, S.-Y.; Lee, K.-S.; Nam, K.-S.
Morin Sensitizes MDA-MB-231 Triple-Negative Breast Cancer Cells to Doxorubicin Cytotoxicity by Suppressing FOXM1 and Attenuating EGFR/STAT3 Signaling Pathways. Pharmaceuticals 2023, 16, 672.
https://doi.org/10.3390/ph16050672
AMA Style
Maharjan S, Lee M-G, Kim S-Y, Lee K-S, Nam K-S.
Morin Sensitizes MDA-MB-231 Triple-Negative Breast Cancer Cells to Doxorubicin Cytotoxicity by Suppressing FOXM1 and Attenuating EGFR/STAT3 Signaling Pathways. Pharmaceuticals. 2023; 16(5):672.
https://doi.org/10.3390/ph16050672
Chicago/Turabian Style
Maharjan, Sushma, Min-Gu Lee, So-Young Kim, Kyu-Shik Lee, and Kyung-Soo Nam.
2023. "Morin Sensitizes MDA-MB-231 Triple-Negative Breast Cancer Cells to Doxorubicin Cytotoxicity by Suppressing FOXM1 and Attenuating EGFR/STAT3 Signaling Pathways" Pharmaceuticals 16, no. 5: 672.
https://doi.org/10.3390/ph16050672
APA Style
Maharjan, S., Lee, M.-G., Kim, S.-Y., Lee, K.-S., & Nam, K.-S.
(2023). Morin Sensitizes MDA-MB-231 Triple-Negative Breast Cancer Cells to Doxorubicin Cytotoxicity by Suppressing FOXM1 and Attenuating EGFR/STAT3 Signaling Pathways. Pharmaceuticals, 16(5), 672.
https://doi.org/10.3390/ph16050672